Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated MyelofibrosisNaveen Pemmaraju,Adam J. Mead,Tim C. P. Somervaille,James K. McCloskey,Francesca Palandri,Steffen Koschmieder,David Lavie,Brian Leber,Su-Peng Yeh, Maria Teresa Gomez-Casares,Emanuele Ammatuna,Ho-Jin Shin,Keita Kirito,Eric Jourdan,Timothy Devos, Hun S. Chuah, Atanas Radinoff,Andrija Bogdanovic, Rastislav Moskal, Qi Jiang, Avijeet S. Chopra, Elektra Papadopoulos, Jalaja Potluri, Francesco PassamontiBLOOD（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
